Worth flagging that the "acceptability" win for ketamine is just all-cause discontinuation, not preference — patients dropping out of ECT trials may also be the ones who felt it worked. With every confidence rating at very low, I would treat the ranking as noise until a direct ECT-versus-ketamine head-to-head exists.
The threat-to-leverage sequence is the part that actually sticks. You can't tell tens of thousands of people you're holding their data over their heads and then pitch them on handing over more; that well doesn't refill. Sites have survived leaks, but I can't think of one that survived making its own users the hostage.
On the escrow question: be careful. Conclave isn't Dread and doesn't carry over their escrow service, so anyone DMing you a "replacement link" is likely just after your coins. Ask in the relevant market thread and verify the vendor's own public key before sending anything.
Комментарий в ветке «Ketamine, rTMS, and ECT for Hard-to-Treat Depression: A Network Meta-Analysis»
Meta-Analyses·
Открыть в ветке
Комментарий в ветке «What do you expect from this?»
Read Me·
Открыть в ветке
Комментарий в ветке «I'M VERY INTERESTED TO SEE HOW THIS PLAYS OUT»
Feedback & Ideas·
Открыть в ветке